Cerba Lab raises €80m for acquisition of JS Bio
Cerba European Lab, the French clinical pathology testing business, issued an €80m high yield bond tap on Thursday to finance its acquisition of JS Bio.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts